Literature DB >> 1793456

Arterial wall oxygenation, oxyradicals, and atherosclerosis.

D W Crawford1, D H Blankenhorn.   

Abstract

The oxygen supply of inner media and thickened intima of atherosclerosis prone arteries depends largely on diffusion from the endothelium. Conditions which increase wall thickness and oxygen diffusion or reduce oxygen transmissibility produce hypoxia and steep PO2 gradients within the wall. Cerebral injury and myocardial reperfusion studies indicate that intermittent hypoxia and steep PO2 gradients lead to oxyradical formation and tissue damage. Products of lipid and sterol peroxidation are found in atherosclerotic plaques and can be generated by arterial wall cells in culture. It is likely that peroxidation occurs directly within the arterial wall. Sufficient oxyradical generation occurs during normal oxygen metabolism that local scavenger mechanisms are required to avoid tissue damage. Experimental hypertension, hyperlipemia and balloon injury produce medial hypoxia with steep PO2 gradients and redistribution of the pattern of arterial wall antioxidant enzymes. This suggests that minor deviations from normal arterial wall anatomy and function can lead to oxyradicals which can be directly injurious and can amplify the atherogenic potential of lipoprotein infiltration.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1793456     DOI: 10.1016/0021-9150(91)90049-9

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  19 in total

Review 1.  Cellular adaptive responses to low oxygen tension: apoptosis and resistance.

Authors:  J K Yun; T S McCormick; R Judware; E G Lapetina
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

2.  Hypoxic remodelling of Ca(2+) signalling in proliferating human arterial smooth muscle.

Authors:  Parvinder K Aley; Jenny A Wilkinson; Claudia C Bauer; John P Boyle; Karen E Porter; Chris Peers
Journal:  Mol Cell Biochem       Date:  2008-07-18       Impact factor: 3.396

3.  Pathophysiological significance of plasma endothelin in peripheral circulatory disturbances.

Authors:  H Nakamura; H Nagase; M Yoshida; T Okazawa; A Okada
Journal:  Environ Health Prev Med       Date:  1996-04       Impact factor: 3.674

Review 4.  Review of progress in sterol oxidations: 1987-1995.

Authors:  L L Smith
Journal:  Lipids       Date:  1996-05       Impact factor: 1.880

5.  Synergy between shear-induced migration and secondary flows on red blood cells transport in arteries: considerations on oxygen transport.

Authors:  Jacopo Biasetti; Pier Giorgio Spazzini; Ulf Hedin; T Christian Gasser
Journal:  J R Soc Interface       Date:  2014-08-06       Impact factor: 4.118

6.  Cu2+ -induced low density lipoprotein peroxidation is dependent on the initial O2 concentration: an O2 consumption study.

Authors:  J K Lodge; M G Traber; P J Sadler
Journal:  Lipids       Date:  2000-10       Impact factor: 1.880

7.  150-kD oxygen-regulated protein is expressed in human atherosclerotic plaques and allows mononuclear phagocytes to withstand cellular stress on exposure to hypoxia and modified low density lipoprotein.

Authors:  Y Tsukamoto; K Kuwabara; S Hirota; J Ikeda; D Stern; H Yanagi; M Matsumoto; S Ogawa; Y Kitamura
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

8.  Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits.

Authors:  C R White; V Darley-Usmar; W R Berrington; M McAdams; J Z Gore; J A Thompson; D A Parks; M M Tarpey; B A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

9.  Effects of free radicals on cytosolic creatine kinase activities and protection by antioxidant enzymes and sulfhydryl compounds.

Authors:  S Genet; R K Kale; N Z Baquer
Journal:  Mol Cell Biochem       Date:  2000-07       Impact factor: 3.396

Review 10.  Hypertensive vascular disease and inflammation: mechanical and humoral mechanisms.

Authors:  W R Taylor
Journal:  Curr Hypertens Rep       Date:  1999 Feb-Mar       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.